15,022 research outputs found
Conformational HIV-1 Envelope on particulate structures: a tool for chemokine coreceptor binding studies
The human immunodeficiency virus type 1 (HIV-1) external envelope glycoprotein gp120 presents conserved binding sites for binding to the primary virus receptor CD4 as well as the major HIV chemokine coreceptors, CCR5 and CXCR4
P05-11. Yeast mannan genetics controls the molecular specificity of anti-carbohydrate antibodies cross-reactive to the HIV envelope
Immunologically self carbohydrates protect the human immunodeficiency virus type -1 (HIV-1) surface glycoprotein, gp120 from antibody recognition. However, one broadly neutralising antibody, 2G12, can protect against primary viral challenge by direct recognition of these "self" glycans on gp120
Kinetics of antiviral activity by human immunodeficiency virus type 1-specific cytotoxic T lymphocytes (CTL) and rapid selection of CTL escape virus in vitro
The antiviral activity of a CD8(+) cytotoxic T-lymphocyte (CTL) clone
(TCC108) directed against a newly identified HLA-B14-restricted epitope,
human immunodeficiency virus type 1 (HIV-1) Rev(67-75) SAEPVPLQL, was
analyzed with respect to its kinetics of target cel
Human Immunodeficiency Virus Type 1 Counseling and Testing Program in the Prenatal Setting
Objective: The objectives of this study were to ascertain the acceptance rate of human immunodeficiency virus type 1 (HIV-1) testing in a high-prevalence area and to describe the sociodemographic
and clinical characteristics of seropositive women diagnosed in the prenatal setting
Ambiguous Nucleotide Calls From Population-based Sequencing of HIV-1 are a Marker for Viral Diversity and the Age of Infection
The fraction of ambiguous nucleotide calls in bulk sequencing of human immunodeficiency virus type 1 (HIV-1) carries important information on viral diversity and the age of infection. In particular, a fraction of ambiguous nucleotides of >.5% provides evidence against a recent infection event <1 year ag
1-Benzyl-2-(1H-indol-3-yl)-5-oxopyrrolidine-2-carbonitrile
In the title compound, C20H17N3O, a potential anti-human immunodeficiency virus type 1 (HIV-1) non-nucleoside reverse-transcriptase inhibitor, the pyrrolidine ring has an envelope conformation. In the crystal structure, adjacent molecules are connected into infinite chains via an N—H⋯O hydrogen bond
CLONING AND MOLECULAR CHARACTERIZATION OF GAG GENE FROM HIV-1 INTO E. COLI DH5A HOST
Considering the worldwide increasing prevalence of human immunodeficiency virus type 1 (HIV-1) infection, World Health Organization (WHO) has intensified the access to the antiretroviral treatment. In spite of that one of the major issues to eradicate HIV-1 is the persistence of proviral human immunodeficiency virus type 1 (HIV-1) DNA reservoir. Although PCR detects HIV-1 DNA, the diagnosis of early, post exposure HIV infection prior to seroconversion can be achieved by the detection of proviral DNA by RTPCR. In the present study HIV-1 DNA were isolated from patient with HIV and using specific primer designed using Primer 3 plus software for the HIV-1 gag gene. The amplified gene was ligated with T vector and transformed into DH5αcells. The plasmid DNA obtained was then confirmed by restriction digestion and sequence analysis. The sequence was found to be 98% similar to that obtained in GenBank. Further research is required to express the gene to get the protein antigen for the production antibodies or effective vaccine for HIV-1.
Considering the worldwide increasing prevalence of human immunodeficiency virus type 1 (HIV-1) infection, World Health Organization (WHO) has intensified the access to the antiretroviral treatment. In spite of that one of the major issues to eradicate HIV-1 is the persistence of proviral human immunodeficiency virus type 1 (HIV-1) DNA reservoir. Although PCR detects HIV-1 DNA, the diagnosis of early, post exposure HIV infection prior to seroconversion can be achieved by the detection of proviral DNA by RTPCR. In the present study HIV-1 DNA were isolated from patient with HIV and using specific primer designed using Primer 3 plus software for the HIV-1 gag gene. The amplified gene was ligated with T vector and transformed into DH5αcells. The plasmid DNA obtained was then confirmed by restriction digestion and sequence analysis. The sequence was found to be 98% similar to that obtained in GenBank. Further research is required to express the gene to get the protein antigen for the production antibodies or effective vaccine for HIV-1
Ambiguous Nucleotide Calls From Population-based Sequencing of HIV-1 are a Marker for Viral Diversity and the Age of Infection
The fraction of ambiguous nucleotide calls in bulk sequencing of human immunodeficiency virus type 1 (HIV-1) carries important information on viral diversity and the age of infection. In particular, a fraction of ambiguous nucleotides of >.5% provides evidence against a recent infection event <1 year ago
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
Antiretroviral therapy that reduces viral replication could limit the transmission of human immunodeficiency virus type 1 (HIV-1) in serodiscordant couples
7-Chloro-11a-phenyl-2,3,5,10,11,11a-hexahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5,11-dione
The title compound, C18H15ClN2O2, is a potential human immunodeficiency virus type-1 (HIV-1) non-nucleoside reverse transcriptase inhibitor. The pyrrolidine ring adopts an envelope and the diazepine ring a boat conformation. In the crystal structure, two isomers (R and S) form centrosymmetric dimers via N—H⋯O hydrogen bonds
- …